Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.
Journal: Journal of neuromuscular diseases
Published: February 06, 2026
Facial Weakness in Facioscapulohumeral Muscular Dystrophy: Objective and Patient-Reported Measures to Guide Reconstructive Interventions.
Journal: Facial plastic surgery & aesthetic medicine
Published: February 04, 2026
Quantitative whole-body MRI in FSHD: assessing systemic involvement and future directions.
Journal: Neuromuscular disorders : NMD
Published: January 26, 2026
Natural history of limb girdle muscular dystrophy R1 (LGMDR1): a GRASP consortium study.
Journal: Neuromuscular disorders : NMD
Published: December 10, 2025
High Burden of Ventricular Arrhythmias and Cardiac Conduction Disease in Pediatric Patients with Pathogenic Desmin (DES) Variants.
Journal: medRxiv : the preprint server for health sciences
Published: November 19, 2025
Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular Dystrophy.
Journal: Annals of neurology
Published: November 14, 2025
Late-onset facioscapulohumeral muscular dystrophy defines a distinct clinical subgroup.
Journal: Neuromuscular disorders : NMD
Published: November 14, 2025
Erratum: Education Research: Embracing the Unknown-Introducing Clinical Uncertainty Into the Neurology Clerkship Curriculum.
Journal: Neurology. Education
Published: September 02, 2025
MRI-Determined Muscle Fat Fractions and Contractile Volumes in Myotonic Dystrophy Type 2.
Journal: Muscle & nerve
Published: August 23, 2025
Electrodiagnostic Studies as a Diagnostic and Prognostic Tool in Acute Flaccid Myelitis.
Journal: Muscle & nerve
Published: August 04, 2025
Education Research: Brick by NeuroBrick-A Collaborative Framework for Digital Content Creation.
Journal: Neurology. Education
Published: June 12, 2025
Quantitative Measurement of Glycosylated ⍺-Dystroglycan as a Biomarker for Disease Severity in Limb-Girdle Muscular Dystrophy Type 2I/R9.
Journal: Neurology. Genetics
Published: June 10, 2025
Last Updated: 09/26/2026